At this time, Eversense^® CGM System is not integrated with (insulin pumps/pens/closed loop systems). We completely understand the importance of integrations with devices. Discussions with potential partners are ongoing, however compatibility with ___ (if brand mentioned acknowledge it, if not say “your pump”) is not available at this time.  Once we have an update on this, we will be sure to announce it.

Eversense^® 365 Sensor is manufactured by Senseonics across the US and Europe.

Eversense^® 365 Transmitter is manufactured by Senseonics in Minnesota, USA.

1. Charge the smart transmitter. Wait until the LED is blinking green or solid green.
2. While connected to the charger, touch and hold the transmitter’s soft-touch button (for approx. 14 seconds). The LED will be white. Remove your finger from the transmitter when the LED changes from white to orange.
3. The LED will start blinking in a few seconds indicating the smart transmitter is going through a self-test sequence. The LED will blink in various colors. Once the self test is complete, the smart transmitter will vibrate and blink green indicating it is now charging.
4. If the self-test does not complete, repeat steps 1 through 3.
5. If step 3 is successfully completed, the smart transmitter is now ready for use.

Eversense^® 365 is a continuous glucose monitoring system indicated for continually measuring glucose levels for up to 1 year in people (18 years or older) with diabetes. The system is indicated for use to replace fingerstick blood glucose measurements for diabetes treatment decisions.

The system is intended to:

• Provide real-time glucose readings.
• Provide glucose trend information.
• Provide alerts for the detection and prediction of episodes of low blood glucose (hypoglycemia) and high blood glucose (hyperglycemia).

The system is intended for single patient use and requires a prescription. Historical data from the system can be interpreted to aid in providing therapy adjustments. These adjustments should be based on patterns and trends seen over time.

The Eversense 365 CGM System is also intended to autonomously communicate with digitally connected devices, including automated insulin dosing (AID) systems. The Eversense 365 CGM System can be used alone or in conjunction with these digitally connected medical devices for the purpose of managing diabetes.

The system is intended for single patient use and requires a prescription.

The Eversense^® 365 CGM System includes 1) a small sensor inserted under the skin by a health care provider, 2) a removable smart transmitter worn over the sensor, and 3) an app to display the glucose readings.

The sensor uses fluorescence to measure glucose in interstitial fluid. It is inserted under the skin and provides glucose readings for up to 1 year.

The sensor uses a unique fluorescent, glucose indicating polymer to measure glucose concentration based on the changes in light.

The removable smart transmitter is worn over the sensor and powers the sensor. It wirelessly sends glucose data (via Bluetooth) to the app. The smart transmitter also provides on-body vibe alerts based on your glucose settings. It has a rechargeable battery and is reusable for up to one year.

The Eversense^® 365 CGM system consists of three main components: a glucose sensor, a Smart Transmitter, and a Mobile Medical Application (CGM Mobile App) to read the glucose data.